Novo Holdings A/S sold AVLN
May 1, 2026 · Form 4 insider transaction
Novo Holdings A/S sold 18,000,000 shares of Avalyn Pharma Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
18,000,000
Price
$0.00
Total value
N/A
InsiderNovo Holdings A/S
Role10% owner
CompanyAvalyn Pharma Inc. (AVLN)
SecuritySeries A Preferred Stock
Transaction codeC: Conversion of a derivative
Transaction dateMay 1, 2026
Filing dateMay 5, 2026
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Series A Preferred Stock, Series B Preferred Stock, Series C-1 Preferred Stock, Series C-2 Preferred Stock and Series D Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-19.2417 basis, and had no expiration date.